| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 130.27M | — |
| Operating expense | — | — |
| Net income | -1.79B | 164.82% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Year to date, 2595.HK has returned +36.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +36.5% |
| All-time high | $43.14 (Apr 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2595.HK would be worth today ›No. GenFleet Therapeutics (Shanghai) Inc. has not paid a dividend in the past 12 months.
GenFleet Therapeutics (Shanghai) Inc. is part of the Healthcare sector.
GenFleet Therapeutics (Shanghai) Inc. has a market cap of 12.49B HKD, based on the latest quote.